Igyxos
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Igyxos has raised €7.5M across 1 funding round from 1 investor, most recently a Series A round in Jan 2019. Based in Nouzilly, France; active in Healthtech. Data as of 28 Oct 2026.
Nouzilly, Francewww.igyxos.com ↗
Total raised
€7.5M
€7,500,000
Funding rounds
1
Investors
1
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearIgyxos — funding by year — interactive chart.
Data table
| Igyxos — funding by year | |
|---|---|
| 2018 | €7.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €7.5M | Bpifrance | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData